Comité Científico internacional

Co-Director of the Centre for Computational Biology, Life Science Initiative (LSI) (Barts Cancer Institute; Queen Mary University of London), Professor of Bioinformatics at Bioinformatics Unit (Molecular Oncology; Barts Cancer Institute; Queen Mary University of London)

Head of the Dermatology Unit at Gustave Roussy and co-director of the Melanoma Research Unit at INSERM 981 Paris-Sud University. 

Head of the Medical Oncology Service at Vall d’Hebron University Hospital in Barcelona, responsible for research, teaching, and patient care in medical oncology. Director of the Vall d’Hebron Institute of Oncology (VHIO). Also leads the Molecular Cancer Therapy Research Unit, a pioneering unit in Spain dedicated to the development of phase I clinical trials in molecular therapies.

Lead faculty statistician for lung cancer research at Mayo Clinic and for the Alliance for Clinical Trials in Oncology and the Alliance Foundation Trials. 

Prof. Harrington is the Head of Division of radiotherapy and imaging and Professor of Biological Cancer Therapies at the ICR. He is Clinical Oncologist specialist in Head & Neck cancer at the Royal Marsden NHS Foundation.

Prof. Karin De Visser – Group Leader of Tumor Biology ¬ Immunology at Netherlands Cancer Institute and Oncode Institute.

Professor Joaquín Martínez MD, PhD. Professor at Universidad Complutense Madrid, Head of Haemathology Service at Hospital 12 de Octubre and Group Leader at Spanish National Cancer Research Center (CNIO) of the Haemathology Unit at the Clinical Research Programme.

Professor Lillian Siu is a senior medical oncologist at the Princess Margaret Cancer Centre, BMO Chair in Precision Genomics and Professor of Medicine at the University of Toronto.

Professor of Medical Oncology. in charge of research, teaching, and patient care in medical oncology and head and neck malignancies at the Section of Oncology of Attikon University Hospital. She also leads a Molecular Oncology laboratory.

Professor Paul S. Mischel, MD, PhD, Professor and Vice Chair of Research for the Department of Pathology. Stanford University School of Medicine. Institute Scholar, ChEM-H, Stanford University. California, US. Former Professor at University of California San Diego and Head of Signaling Group – Tumor Biology at Ludwig Cancer Research - San Diego US

Professor Rajesh Chopra MD PhD, Apple Tree Partner (ATP), Venture Partner - London, UK. Former Head of the Division of Cancer Therapeutics, Institute of Cancer Research and Royal Marsden Hospital. Professor Rajesh Chopra is an experienced scientist and clinical leader who has discovered and developed novel cancer therapies, including molecularly targeted and cellular approaches. He is Head of the Division of Cancer Therapeutics and Director of the Cancer Research UK Cancer Therapeutics Unit, and his main areas of expertise are in haematological oncology, solid tumour biology, transplantation and cell therapies.

Secretary of CRIS International Scientific Committee